a strong trendp = 0.06
which were markedly reduced by LP AS21-augmented MSA treatment, with significant MPO reduction in S_MSA and T_MSA groups ( p < 0.05), and a strong trend toward MDA reduction in T_MSA ( p = 0.06).
which were markedly reduced by LP AS21-augmented MSA treatment, with significant MPO reduction in S_MSA and T_MSA groups ( p < 0.05), and a strong trend toward MDA reduction in T_MSA ( p = 0.06).